A Nattokinase‐Loaded Nanozyme for Alleviating Acute Myocardial Infarction via Thrombolysis and Antioxidation
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202402763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yingchao Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fuwai Central-China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, 450046, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Antioxidants, Subtilisins, Thrombolytic Therapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Young Elite Scientists Sponsorship Program by the Henan Association for Science and Technology, Medical Science and Technology Project of Henan Province, Henan Provincial Joint Fund of Science and Technology Research and Development Program.
Abstract (Originalsprache)
Acute myocardial infarction (MI) induced by thrombus formation is a prevalent cardiovascular disorder, and thrombolytic therapy continues to be a principal treatment modality. Prior research indicates a substantial association among MI, thrombosis, and the activation of oxidative stress pathways. The effectiveness of current thrombolytic drugs is relatively constrained, and the need for innovative and versatile thrombolytic medications remains critical. Nattokinase (NK) is a naturally‐occurring enzyme known for its thrombolytic characteristics. Nonetheless, nattokinase's limited stability and susceptibility to inactivation in biological systems have impeded its clinical utility. This study designs a manganese oxide nanozyme (MnOx) loaded with NK (MnOx@NK), which exhibits both antioxidant and thrombolytic function. The administration of MnOx@NK through tail vein injection significantly restores vascular function and further reduces myocardial injury in a mouse model of myocardial infarction, demonstrating a pronounced protective effect against oxidative stress. These findings indicate that nattokinase‐loaded nanozymes can be a promising approach for treating acute myocardial infarction, providing a new strategy for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fuwai Central-China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, 450046, China.
- National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiov…
- Zhengzhou Key Laboratory of Cardiovascular Aging Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, 451464, China.
- Department of Cardiology, Peking University People's Hospital, Beijing, 100044, China.
ORCID-Profile: Wei Jiang
Förderung
- Young Elite Scientists Sponsorship Program by the Henan Association for Science and Technology
- Medical Science and Technology Project of Henan Province
- Henan Provincial Joint Fund of Science and Technology Research and Development Program
- Natural Science Foundation of Henan Province
Zitieren
APA
Shi, Y., Liu, C., Gui, Y., Guo, Y., Zhang, Y., Pan, J., Tang, H., Gao, C., Xing, J., Han, Y., & Jiang, W. (2025). A Nattokinase‐Loaded Nanozyme for Alleviating Acute Myocardial Infarction via Thrombolysis and Antioxidation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402763
Vancouver
Shi Y, Liu C, Gui Y, Guo Y, Zhang Y, Pan J, et al. A Nattokinase‐Loaded Nanozyme for Alleviating Acute Myocardial Infarction via Thrombolysis and Antioxidation. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402763
BibTeX
@article{Shi2025,
author = {Shi, Yingchao and Liu, Chuanfen and Gui, Yuesheng and Guo, Yike and Zhang, Yuanhao and Pan, Jiangpeng and Tang, Hao and Gao, Chuanyu and Xing, Junyue and Han, Yu and Jiang, Wei},
title = {A Nattokinase‐Loaded Nanozyme for Alleviating Acute Myocardial Infarction via Thrombolysis and Antioxidation},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202402763}
}
EUVIMED